ENZN - Enzon Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 510.61M
Enterprise Value 37.05M
Trailing P/E 1.83
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.55
Price/Book (mrq)0.89
Enterprise Value/Revenue 31.03
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) -0.18
52-Week Change 3-10.74%
S&P500 52-Week Change 36.70%
52 Week High 30.2900
52 Week Low 30.1900
50-Day Moving Average 30.2509
200-Day Moving Average 30.2429

Share Statistics

Avg Vol (3 month) 322.34k
Avg Vol (10 day) 319.17k
Shares Outstanding 544.21M
Float 28.09M
% Held by Insiders 113.11%
% Held by Institutions 124.43%
Shares Short (Apr 29, 2016) 4157.47k
Short Ratio (Apr 29, 2016) 41.03
Short % of Float (Apr 29, 2016) 40.41%
Short % of Shares Outstanding (Apr 29, 2016) 40.36%
Shares Short (prior month Mar 31, 2016) 4507.66k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 21, 2019
Ex-Dividend Date 4Feb 20, 2019
Last Split Factor (new per old) 21/1
Last Split Date 3Sep 29, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 84.50%
Operating Margin (ttm)84.60%

Management Effectiveness

Return on Assets (ttm)33.16%
Return on Equity (ttm)55.67%

Income Statement

Revenue (ttm)6.85M
Revenue Per Share (ttm)0.16
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)6.92M
EBITDA N/A
Net Income Avi to Common (ttm)5.79M
Diluted EPS (ttm)0.1310
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.56M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)19.80
Book Value Per Share (mrq)0.27

Cash Flow Statement

Operating Cash Flow (ttm)-1.03M
Levered Free Cash Flow (ttm)-4.17M